Dietary carbohydrates and fatty liver disease: de novo lipogenesis

被引:57
|
作者
Chiu, Sally [1 ,2 ]
Mulligan, Kathleen [1 ,3 ,4 ]
Schwarz, Jean-Marc [1 ,3 ,4 ]
机构
[1] Touro Univ Calif, Coll Osteopath Med, 1310 Club Dr, Vallejo, CA 94592 USA
[2] Childrens Hosp Oakland, Res Inst, Oakland, CA 94609 USA
[3] Univ Calif San Francisco, Dept Med, San Francisco, CA USA
[4] Zuckerberg San Francisco Gen Hosp, Div Endocrinol, San Francisco, CA USA
基金
美国国家卫生研究院;
关键词
carbohydrate; fructose; lipogenesis; nonalcoholic fatty liver disease; sugar; FRUCTOSE CORN SYRUP; HEPATIC LIPOGENESIS; IN-VIVO; STEATOSIS; CHILDREN; RESTRICTION; INHIBITION; SUGAR; CONSUMPTION; PREVALENCE;
D O I
10.1097/MCO.0000000000000469
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose of reviewTo review recent evidence for the role of dietary carbohydrate in de novo lipogenesis (DNL) and nonalcoholic fatty liver disease (NAFLD).Recent findingsA large body of evidence suggests that increased hepatic DNL is a significant pathway contributing to the development of NAFLD. Dietary carbohydrates, in particular, fructose, have been shown to stimulate DNL and increase liver fat, although it is debated whether this is due to excess energy or fructose per se. Recent dietary intervention studies conducted in energy balance show that high-fructose diets increase DNL and liver fat, whereas fructose restriction decreases DNL and liver fat.SummaryThe association of high-carbohydrate and high-sugar diets with NAFLD may in part be explained by the effect of sugar on increasing hepatic DNL.
引用
收藏
页码:277 / 282
页数:6
相关论文
共 50 条
  • [21] Chokeberry attenuates the expression of genes related to de novo lipogenesis in the hepatocytes of mice with nonalcoholic fatty liver disease
    Park, Hyunjin
    Liu, Yanan
    Kim, Hyun-Sook
    Shin, Jung-Hee
    NUTRITION RESEARCH, 2016, 36 (01) : 57 - 64
  • [22] Vitamin C Deficiency Inhibits Nonalcoholic Fatty Liver Disease Progression through Impaired de Novo Lipogenesis
    Lee, Seoung-Woo
    Baek, Su-Min
    Kang, Kyung-Ku
    Lee, A-Rang
    Kim, Tae-Un
    Choi, Seong-Kyoon
    Roh, Yoon-Seok
    Hong, Il-Hwa
    Park, Sang-Joon
    Kim, Tae-Hwan
    Jeong, Kyu-Shik
    Park, Jin-Kyu
    AMERICAN JOURNAL OF PATHOLOGY, 2021, 191 (09): : 1550 - 1563
  • [23] Nox1 Inhibition Attenuates Non-Alcoholic Fatty Liver Disease and De Novo Lipogenesis
    Larion, Sebastian
    Thompson, Jennifer
    Butcher, Josh
    Haigh, Stephen
    Mintz, James
    Khurana, Sandeep
    Fulton, David
    Stepp, David
    FASEB JOURNAL, 2017, 31
  • [24] The Association of Nicotinamide Phosphoribosyltransferase Polymorphism with Markers of Hepatic Injury and De Novo Lipogenesis in Nonalcoholic Fatty Liver Disease
    Amirkalali, Bahareh
    Sohrabi, Masoud Reza
    Rahimi-Moghaddam, Parvaneh
    Esrafily, Ali
    Gholami, Ali
    Hosseinzadeh, Payam
    Keyvani, Hossein
    Shidfar, Farzad
    Zamani, Farhad
    HEPATITIS MONTHLY, 2017, 17 (06)
  • [25] Androsin alleviates non-alcoholic fatty liver disease by activating autophagy and attenuating de novo lipogenesis
    Singh, Abhinav
    Ansari, Alisha
    Gupta, Jay
    Singh, Himalaya
    Jagavelu, Kumaravelu
    V. Sashidhara, Koneni
    PHYTOMEDICINE, 2024, 129
  • [26] Fatty Liver Due to Increased de novo Lipogenesis: Alterations in the Hepatic Peroxisomal Proteome
    Knebel, Birgit
    Fahlbusch, Pia
    Dille, Matthias
    Wahlers, Natalie
    Hartwig, Sonja
    Jacob, Sylvia
    Kettel, Ulrike
    Schiller, Martina
    Herebian, Diran
    Koellmer, Cornelia
    Lehr, Stefan
    Mueller-Wieland, Dirk
    Kotzka, Jorg
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2019, 7
  • [27] Effects of enteral carbohydrates on de novo lipogenesis in critically ill patients
    Schwarz, JM
    Chioléro, R
    Revelly, JP
    Cayeux, C
    Schneiter, P
    Jéquier, E
    Chen, T
    Tappy, L
    AMERICAN JOURNAL OF CLINICAL NUTRITION, 2000, 72 (04): : 940 - 945
  • [28] CROSS TALK BETWEEN ER STRESS AND DE NOVO LIPOGENESIS AND ITS IMPLICATIONS FOR INSULIN RESISTANCE AND FATTY LIVER DISEASE
    Ye, J.
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2013, 40 : 23 - 24
  • [29] In-depth analysis of de novo lipogenesis in non-alcoholic fatty liver disease: Mechanism and pharmacological interventions*
    Zhu, Zhixian
    Zhang, Xiaoxun
    Pan, Qiong
    Zhang, Liangjun
    Chai, Jin
    LIVER RESEARCH, 2023, 7 (04) : 285 - 295
  • [30] Raphani Semen (Raphanus sativus L.) Ameliorates Alcoholic Fatty Liver Disease by Regulating De Novo Lipogenesis
    Park, Woo Yong
    Song, Gahee
    Noh, Joon Hak
    Kim, Taegon
    Kim, Jae Jin
    Hong, Seokbeom
    Park, Jinbong
    Um, Jae-Young
    NUTRIENTS, 2021, 13 (12)